Verification of an optimizer algorithm by the beam delivery evaluation of intensity-modulated arc therapy plans

1 Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144: 1941-53. doi: 10.1002/ijc.31937Ferlay J Colombet M Soerjomataram I Mathers C Parkin DM Piñeros M et al Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods Int J Cancer 2019 144 1941 53 10.1002/ijc.3193730350310Open DOISearch in Google Scholar

2 Maciejczyk A, Skrzypczyńska I, Janiszewska M. Lung cancer. Radiotherapy in lung cancer: actual methods and future trends. Reports Pract Oncol Radiother 2014; 19: 35360. doi: 10.1016/j.rpor.2014.04.012Maciejczyk A Skrzypczyńska I Janiszewska M Lung cancer Radiotherapy in lung cancer: actual methods and future trends. Reports Pract Oncol Radiother 2014 19 35360 10.1016/j.rpor.2014.04.012420177625337407Open DOISearch in Google Scholar

3 Videtic GMM., Donington J., Giuliani M., et al. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol 2017; 7: 295-301. doi: 10.1016/j.prro.2017.04.014Videtic GMM. Donington J. Giuliani M. et al Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO Evidence-Based Guideline Pract Radiat Oncol 2017 7 295 301 10.1016/j.prro.2017.04.01428596092Open DOISearch in Google Scholar

4 Cheng M, Jolly S, Quarshie WO, Kapadia N, Vigneau FD, Kong FM. Modern radiation further improves survival in non-small cell lung cancer: an analysis of 288,670 patients. J Cancer 2019; 10: 168-77. doi: 10.7150/jca.26600Cheng M Jolly S Quarshie WO Kapadia N Vigneau FD Kong FM Modern radiation further improves survival in non-small cell lung cancer: an analysis of 288,670 patients J Cancer 2019 10 168 77 10.7150/jca.26600632984830662537Open DOISearch in Google Scholar

5 Vinod SK, Hau E. Radiotherapy treatment for lung cancer: current status and future directions. Respirology 2020; 25(Suppl 2): 61-71. doi: 10.1111/resp.13870Vinod SK Hau E Radiotherapy treatment for lung cancer: current status and future directions Respirology 2020 25 Suppl 2 61 71 10.1111/resp.1387032516852Open DOISearch in Google Scholar

6 Shah JL, Loo BW. Stereotactic ablative radiotherapy for early-stage lung cancer. Semin Radiat Oncol 2017; 27: 218-28. doi: 10.1016/j.semradonc.2017.03.001Shah JL Loo BW Stereotactic ablative radiotherapy for early-stage lung cancer Semin Radiat Oncol 2017 27 218 28 10.1016/j.semradonc.2017.03.00128577829Open DOISearch in Google Scholar

7 Tian S, Higgins KA, Curran WJ, Cassidy RJ. Stereotactic body radiation therapy vs. surgery in early-stage nonsmall cell lung cancer: lessons learned, current recommendations, future directions. J Thorac Dis 2018; 10: 1201-4. doi: 10.21037/jtd.2018.01.161Tian S Higgins KA Curran WJ Cassidy RJ Stereotactic body radiation therapy vs surgery in early-stage nonsmall cell lung cancer: lessons learned, current recommendations, future directions. J Thorac Dis 2018 10 1201 4 10.21037/jtd.2018.01.161590637529708180Open DOISearch in Google Scholar

8 Shinde A, Li R, Kim J, Salgia R, Hurria A, Amini A. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly. Semin Oncol 2018; 45: 2010-9. doi: 10.1053/j.seminoncol.2018.06.002Shinde A Li R Kim J Salgia R Hurria A Amini A Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly Semin Oncol 2018 45 2010 9 10.1053/j.seminoncol.2018.06.00230286944Open DOISearch in Google Scholar

9 Chi A, Fang W, Sun Y, Wen S. Comparison of long-term survival of patients with early-stage non-small cell lung cancer after surgery vs stereotactic body radiotherapy. JAMA Netw Open 2019; 2: e1915724. doi: 10.1001/jamanetworkopen.2019.15724Chi A Fang W Sun Y Wen S Comparison of long-term survival of patients with early-stage non-small cell lung cancer after surgery vs stereotactic body radiotherapy JAMA Netw Open 2019 2 e1915724 10.1001/jamanetworkopen.2019.15724690281331747032Open DOISearch in Google Scholar

10 Lagerwaard FJ, Haasbeek CJA, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;70: 685-92. doi: 10.1016/j.ijrobp.2007.10.053Lagerwaard FJ Haasbeek CJA Smit EF Slotman BJ Senan S Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 200870 685 92 10.1016/j.ijrobp.2007.10.05318164849Open DOISearch in Google Scholar

11 De Ruysscher D, Faivre-Finn C, Moeller D, Nestle U, Hurkmans CW, Le Péchoux C, et al. European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. Radiother Oncol 2017; 124: 1-10. doi: 10.1016/j.radonc.2017.06.003De Ruysscher D Faivre-Finn C Moeller D Nestle U Hurkmans CW Le Péchoux C et al European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer Radiother Oncol 2017 124 1 10 10.1016/j.radonc.2017.06.00328666551Open DOISearch in Google Scholar

12 Guckenberger M, Andratschke N, Dieckmann K, Hoogeman MS, Hoyer M, Hurkmans C, et al. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother Oncol 2017; 124: 11-7. doi: 10.1016/j.radonc.2017.05.012Guckenberger M Andratschke N Dieckmann K Hoogeman MS Hoyer M Hurkmans C et al ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer Radiother Oncol 2017 124 11 7 10.1016/j.radonc.2017.05.01228687397Open DOISearch in Google Scholar

13 Temming S, Kocher M, Stoelben E, Hagmeyer L, Chang DH, Frank K, et al. Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer. Strahlentherapie Und Onkol 2018; 194: 91-7. doi: 10.1007/s00066-017-1194-xTemming S Kocher M Stoelben E Hagmeyer L Chang DH Frank K et al Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer Strahlentherapie Und Onkol 2018 194 91 7 10.1007/s00066-017-1194-x28812120Open DOISearch in Google Scholar

14 de Jong EEC, Guckenberger M, Andratschke N, Dieckmann K, Hoogeman MS, Milder M, et al. Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91. Radiother Oncol 2020; 142: 217-23. doi: 10.1016/j.radonc.2019.11.001de Jong EEC Guckenberger M Andratschke N Dieckmann K Hoogeman MS Milder M et al Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91 Radiother Oncol 2020 142 217 23 10.1016/j.radonc.2019.11.00131767472Open DOISearch in Google Scholar

15 Ruggieri R, Stavrev P, Naccarato S, Stavreva N, Alongi F, Nahum AE. Optimal dose and fraction number in SBRT of lung tumours: A radiobiological analysis. Phys Medica 2017; 44: 188-95. doi: 10.1016/j.ejmp.2016.12.012Ruggieri R Stavrev P Naccarato S Stavreva N Alongi F Nahum AE Optimal dose and fraction number in SBRT of lung tumours: A radiobiological analysis Phys Medica 2017 44 188 95 10.1016/j.ejmp.2016.12.01228130055Open DOISearch in Google Scholar

16 Atalar B, Mustafayev TZ, Sio TT, Sahin B, Gungor G, Aydın G, et al. Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors. Radiol Oncol 2020; 54: 4807. doi: 10.2478/raon-2020-0039Atalar B Mustafayev TZ Sio TT Sahin B Gungor G Aydın G et al Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors Radiol Oncol 2020 54 4807 10.2478/raon-2020-0039758533432589607Open DOISearch in Google Scholar

17 Widder J, Hollander M, Ubbels JF, Bolt RA, Langendijk JA. Optimizing dose prescription in stereotactic body radiotherapy for lung tumours using Monte Carlo dose calculation. Radiother Oncol 2010; 94: 42-6. doi: 10.1016/j.radonc.2009.11.008Widder J Hollander M Ubbels JF Bolt RA Langendijk JA Optimizing dose prescription in stereotactic body radiotherapy for lung tumours using Monte Carlo dose calculation Radiother Oncol 2010 94 42 6 10.1016/j.radonc.2009.11.00820022394Open DOISearch in Google Scholar

18 Ewing MM, Desrosiers C, Fakiris AJ, DeBliek CR, Kiszka DN, Stinson ER, et al. Conformality study for stereotactic radiosurgery of the lung. Med Dosim 2011; 36: 14-20. doi: 10.1016/j.meddos.2009.10.004Ewing MM Desrosiers C Fakiris AJ DeBliek CR Kiszka DN Stinson ER et al Conformality study for stereotactic radiosurgery of the lung Med Dosim 2011 36 14 20 10.1016/j.meddos.2009.10.00420110162Open DOISearch in Google Scholar

19 Chan M, Wong M, Leung R, Cheung S, Blanck O. Optimizing the prescription isodose level in stereotactic volumetric-modulated arc radiotherapy of lung lesions as a potential for dose de-escalation. Radiat Oncol 2018; 13: 1-11. doi: 10.1186/s13014-018-0965-6Chan M Wong M Leung R Cheung S Blanck O Optimizing the prescription isodose level in stereotactic volumetric-modulated arc radiotherapy of lung lesions as a potential for dose de-escalation Radiat Oncol 2018 13 1 11 10.1186/s13014-018-0965-6580782329426358Open DOISearch in Google Scholar

20 Meng MB, Wang HH, Zaorsky NG, Sun BS, Zhu L, Song YC, et al. Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer. Cancer Sci 2019; 110: 3553-64. doi: 10.1111/cas.14185Meng MB Wang HH Zaorsky NG Sun BS Zhu L Song YC et al Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer Cancer Sci 2019 110 3553 64 10.1111/cas.14185682501231464032Open DOISearch in Google Scholar

21 Tsurugai Y, Takeda A, Sanuki N, Eriguchi T, Aoki Y, Oku Y, et al. Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume. J Radiat Res 2019; 60: 364-70. doi: 10.1093/jrr/rry112Tsurugai Y Takeda A Sanuki N Eriguchi T Aoki Y Oku Y et al Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume J Radiat Res 2019 60 364 70 10.1093/jrr/rry112653062730668868Open DOISearch in Google Scholar

22 Oku Y, Takeda A, Kunieda E, Sudo Y, Oooka Y, Aoki Y, et al. Analysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapy. Pract Radiat Oncol 2012; 2: 46-53. doi: 10.1016/j.prro.2011.06.001Oku Y Takeda A Kunieda E Sudo Y Oooka Y Aoki Y et al Analysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapy Pract Radiat Oncol 2012 2 46 53 10.1016/j.prro.2011.06.00124674036Open DOISearch in Google Scholar

23 Ding C, Solberg T, Xing L, Heinzerling J, Timmerman R. SU-E-T-451: optimization of normalized prescription isodose selection for stereotactic radiation therapy: conventional vs. robotic linac. Med Phys 2012; 39: 3808-9. doi: 10.1118/1.4735540Ding C Solberg T Xing L Heinzerling J Timmerman R SU-E-T-451: optimization of normalized prescription isodose selection for stereotactic radiation therapy: conventional vs robotic linac. Med Phys 2012 39 3808 9 10.1118/1.473554028517448Open DOISearch in Google Scholar

24 Zheng D, Zhang Q, Liang X, Zhu X, Verma V, Wang S, et al. Effect of the normalized prescription isodose line on the magnitude of Monte Carlo vs. pencil beam target dose differences for lung stereotactic body radiotherapy. J Appl Clin Med Phys 2016; 17: 48-58. doi: 10.1120/jacmp.v17i4.5965Zheng D Zhang Q Liang X Zhu X Verma V Wang S et al Effect of the normalized prescription isodose line on the magnitude of Monte Carlo vs pencil beam target dose differences for lung stereotactic body radiotherapy. J Appl Clin Med Phys 2016 17 48 58 10.1120/jacmp.v17i4.5965569005327455476Open DOISearch in Google Scholar

25 Dickey M, Roa W, Drodge S, Ghosh S, Murray B, Scrimger R, et al. A planning comparison of 3-dimensional conformal multiple static field, conformal arc, and volumetric modulated arc therapy for the delivery of stereotactic body radiotherapy for early stage lung cancer. Med Dosim 2015; 40: 347-51. doi: 10.1016/j.meddos.2015.04.006Dickey M Roa W Drodge S Ghosh S Murray B Scrimger R et al A planning comparison of 3-dimensional conformal multiple static field, conformal arc, and volumetric modulated arc therapy for the delivery of stereotactic body radiotherapy for early stage lung cancer Med Dosim 2015 40 347 51 10.1016/j.meddos.2015.04.00626027510Open DOISearch in Google Scholar

26 Schwarz M, Cattaneo GM, Marrazzo L. Geometrical and dosimetrical uncertainties in hypofractionated radiotherapy of the lung: a review. Phys Medica 2017; 36: 126-39. doi: 10.1016/j.ejmp.2017.02.011Schwarz M Cattaneo GM Marrazzo L Geometrical and dosimetrical uncertainties in hypofractionated radiotherapy of the lung: a review Phys Medica 2017 36 126 39 10.1016/j.ejmp.2017.02.01128238577Open DOISearch in Google Scholar

27 Younge KC, Roberts D, Janes LA, Anderson C, Moran JM, Matuszak MM. Predicting deliverability of volumetric-modulated arc therapy (VMAT) plans using aperture complexity analysis. J Appl Clin Med Phys 2016; 17: 124-31. doi: 10.1120/jacmp.v17i4.6241Younge KC Roberts D Janes LA Anderson C Moran JM Matuszak MM Predicting deliverability of volumetric-modulated arc therapy (VMAT) plans using aperture complexity analysis J Appl Clin Med Phys 2016 17 124 31 10.1120/jacmp.v17i4.6241534548427455504Open DOISearch in Google Scholar

28 Yaparpalvi R, Garg MK, Shen J, Bodner WR, Mynampati DK, Gafar A, et al. Evaluating which plan quality metrics are appropriate for use in lung SBRT. Br J Radiol 2018; 91: 1-8. doi: 10.1259/bjr.20170393Yaparpalvi R Garg MK Shen J Bodner WR Mynampati DK Gafar A et al Evaluating which plan quality metrics are appropriate for use in lung SBRT Br J Radiol 2018 91 1 8 10.1259/bjr.20170393596548529227151Open DOISearch in Google Scholar

29 Feuvret L, Noël G, Mazeron JJ, Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys 2006; 64: 333-42. doi: 10.1016/j.ijrobp.2005.09.028Feuvret L Noël G Mazeron JJ Bey P Conformity index: a review Int J Radiat Oncol Biol Phys 2006 64 333 42 10.1016/j.ijrobp.2005.09.02816414369Open DOISearch in Google Scholar

30 Esch A Van, Huyskens DP, Hirschi L, Scheib S, Baltes C. Optimized varian aSi portal dosimetry: development of datasets for collective use. J Appl Clin Med Phys 2013; 14: 82-99. doi: 10.1120/jacmp.v14i6.4286Esch A Van Huyskens DP Hirschi L Scheib S Baltes C Optimized varian aSi portal dosimetry: development of datasets for collective use J Appl Clin Med Phys 2013 14 82 99 10.1120/jacmp.v14i6.4286571463524257272Open DOISearch in Google Scholar

31 Moghadam SE, Nasseri S, Seyedi SS, Gholamhosseinian H, Momennezhad M. Evaluation of application of EPID for rapid QC testing of linear accelerator. Reports Pract Oncol Radiother 2018; 23: 369-77. doi: 10.1016/j.rpor.2018.07.008Moghadam SE Nasseri S Seyedi SS Gholamhosseinian H Momennezhad M Evaluation of application of EPID for rapid QC testing of linear accelerator Reports Pract Oncol Radiother 2018 23 369 77 10.1016/j.rpor.2018.07.008609740730127677Open DOISearch in Google Scholar

32 Min S, Choi YE, Kwak J, Cho B. Practical approach for pretreatment verification of IMRT with flattening filter-free (FFF) beams using varian portal dosimetry. J Appl Clin Med Phys 2015; 16: 40-50. doi: 10.1120/jacmp.v16i1.4934Min S Choi YE Kwak J Cho B Practical approach for pretreatment verification of IMRT with flattening filter-free (FFF) beams using varian portal dosimetry J Appl Clin Med Phys 2015 16 40 50 10.1120/jacmp.v16i1.4934568998725679149Open DOISearch in Google Scholar

33 Barbeiro AR, Parent L, Vieillevigne L, Ferrand R, Franceries X. Dosimetric performance of continuous EPID imaging in stereotactic treatment conditions. Phys Medica 2020; 78: 117-22. doi: 10.1016/j.ejmp.2020.09.009Barbeiro AR Parent L Vieillevigne L Ferrand R Franceries X Dosimetric performance of continuous EPID imaging in stereotactic treatment conditions Phys Medica 2020 78 117 22 10.1016/j.ejmp.2020.09.00932980588Open DOISearch in Google Scholar

34 Xu Z, Kim J, Han J, Hsia AT, Ryu S. Dose rate response of digital megavolt imager detector for flattening filter-free beams. J Appl Clin Med Phys 2018; 19: 141-7. doi: 10.1002/acm2.12358Xu Z Kim J Han J Hsia AT Ryu S Dose rate response of digital megavolt imager detector for flattening filter-free beams J Appl Clin Med Phys 2018 19 141 7 10.1002/acm2.12358603639929781165Open DOISearch in Google Scholar

35 Pardo E, Novais JC, López MYM, Maqueda SR. On flattening filter-free portal dosimetry. J Appl Clin Med Phys 2016; 17: 132-45. doi: 10.1120/jacmp.v17i4.6147Pardo E Novais JC López MYM Maqueda SR On flattening filter-free portal dosimetry J Appl Clin Med Phys 2016 17 132 45 10.1120/jacmp.v17i4.6147569003927455487Open DOISearch in Google Scholar

36 Miri N, Keller P, Zwan BJ, Greer P. EPID-based dosimetry to verify IMRT planar dose distribution for the aS1200 EPID and FFF beams. J Appl Clin Med Phys 2016; 17: 292-304. doi: 10.1120/jacmp.v17i6.6336Miri N Keller P Zwan BJ Greer P EPID-based dosimetry to verify IMRT planar dose distribution for the aS1200 EPID and FFF beams J Appl Clin Med Phys 2016 17 292 304 10.1120/jacmp.v17i6.6336569049427929502Open DOISearch in Google Scholar

37 Xia Y, Adamson J, Zlateva Y, Giles W. Application of TG-218 action limits to SRS and SBRT pre-treatment patient specific QA. J Radiosurgery SBRT 2020; 7: 135-47. PMID: 33282467Xia Y Adamson J Zlateva Y Giles W Application of TG-218 action limits to SRS and SBRT pre-treatment patient specific QA J Radiosurgery SBRT 2020 7 135 47 PMID: 33282467Search in Google Scholar

38 Alharthi T, Arumugam S, Vial P, Holloway L, Thwaites D. EPID sensitivity to delivery errors for pre-treatment verification of lung SBRT VMAT plans. Phys Medica 2019; 59: 37-46. doi: 10.1016/j.ejmp.2019.02.007Alharthi T Arumugam S Vial P Holloway L Thwaites D EPID sensitivity to delivery errors for pre-treatment verification of lung SBRT VMAT plans Phys Medica 2019 59 37 46 10.1016/j.ejmp.2019.02.00730928064Open DOISearch in Google Scholar

39 Son J, Baek T, Lee B, Shin D, Park SY, Park J, et al. A comparison of the quality assurance of four dosimetric tools for intensity modulated radiation therapy. Radiol Oncol 2015; 49: 307-13. doi: 10.1515/raon-2015-0021Son J Baek T Lee B Shin D Park SY Park J et al A comparison of the quality assurance of four dosimetric tools for intensity modulated radiation therapy Radiol Oncol 2015 49 307 13 10.1515/raon-2015-0021457722926401138Open DOISearch in Google Scholar

40 Radojcic DS, Rajlic D, Casar B, Kolacio MS, Obajdin N, Faj D, et al. Evaluation of two-dimensional dose distributions for pre-treatment patient-specific IMRT dosimetry. Radiol Oncol 2018; 52: 346-52. doi: 10.2478/raon-2018-0019Radojcic DS Rajlic D Casar B Kolacio MS Obajdin N Faj D et al Evaluation of two-dimensional dose distributions for pre-treatment patient-specific IMRT dosimetry Radiol Oncol 2018 52 346 52 10.2478/raon-2018-0019613735630210046Open DOISearch in Google Scholar

41 Hernandez V, Saez J, Pasler M, Jurado-Bruggeman D, Jornet N. Comparison of complexity metrics for multi-institutional evaluations of treatment plans in radiotherapy. Phys Imaging Radiat Oncol 2018; 5: 37-43. doi: 10.1016/j.phro.2018.02.002Hernandez V Saez J Pasler M Jurado-Bruggeman D Jornet N Comparison of complexity metrics for multi-institutional evaluations of treatment plans in radiotherapy Phys Imaging Radiat Oncol 2018 5 37 43 10.1016/j.phro.2018.02.002780758833458367Open DOISearch in Google Scholar

42 Chiavassa S, Bessieres I, Edouard M, Mathot M, Moignier A. Complexity metrics for IMRT and VMAT plans: a review of current literature and applications. Br J Radiol 2019; 92. doi: 10.1259/bjr.20190270Chiavassa S Bessieres I Edouard M Mathot M Moignier A Complexity metrics for IMRT and VMAT plans: a review of current literature and applications Br J Radiol 2019 92 10.1259/bjr.20190270677459931295002Open DOISearch in Google Scholar

43 Xu Z, Wang IZ, Kumaraswamy LK, Podgorsak MB. Evaluation of dosimetric effect caused by slowing with multi-leaf collimator (MLC) leaves for volumetric modulated arc therapy (VMAT). Radiol Oncol 2016; 50: 121-8. doi: 10.1515/raon-2016-0008Xu Z Wang IZ Kumaraswamy LK Podgorsak MB Evaluation of dosimetric effect caused by slowing with multi-leaf collimator (MLC) leaves for volumetric modulated arc therapy (VMAT) Radiol Oncol 2016 50 121 8 10.1515/raon-2016-0008482533427069458Open DOISearch in Google Scholar

44 Park JM, Park SY, Kim H. Modulation index for VMAT considering both mechanical and dose calculation uncertainties. Phys Med Biol 2015; 60: 7101-25. doi: 10.1088/0031-9155/60/18/7101Park JM Park SY Kim H Modulation index for VMAT considering both mechanical and dose calculation uncertainties Phys Med Biol 2015 60 7101 25 10.1088/0031-9155/60/18/710126317697Open DOISearch in Google Scholar

45 Park JM, Wu HG, Kim JH, Carlson JNK, Kim K. The effect of MLC speed and acceleration on the plan delivery accuracy of VMAT. Br J Radiol 2015; 88: 16-24. doi: 10.1259/bjr.20140698Park JM Wu HG Kim JH Carlson JNK Kim K The effect of MLC speed and acceleration on the plan delivery accuracy of VMAT Br J Radiol 2015 88 16 24 10.1259/bjr.20140698462847725734490Open DOISearch in Google Scholar

46 Glenn MC, Hernandez V, Saez J, Followill DS, Howell RM, Pollard-Larkin JM, et al. Treatment plan complexity does not predict IROC Houston anthropomorphic head and neck phantom performance. Phys Med Biol 2018; 63. doi: 10.1088/1361-6560/aae29eGlenn MC Hernandez V Saez J Followill DS Howell RM Pollard-Larkin JM et al Treatment plan complexity does not predict IROC Houston anthropomorphic head and neck phantom performance Phys Med Biol 2018 63 10.1088/1361-6560/aae29e628726830230475Open DOISearch in Google Scholar

47 Abdellatif A, Gaede S. Control Point Analysis comparison for 3 different treatment planning and delivery complexity levels using a commercial 3-dimensional diode array. Med Dosim 2014; 39: 174-9. doi: 10.1016/j.meddos.2013.12.005Abdellatif A Gaede S Control Point Analysis comparison for 3 different treatment planning and delivery complexity levels using a commercial 3-dimensional diode array Med Dosim 2014 39 174 9 10.1016/j.meddos.2013.12.00524480374Open DOISearch in Google Scholar

48 Huang L, Zhuang T, Mastroianni A, Djemil T, Cui T, Xia P. Impact of small MU/segment and dose rate on delivery accuracy of volumetric-modulated arc therapy (VMAT). J Appl Clin Med Phys 2016; 17: 203-10. doi: 10.1120/jacmp.v17i3.6046Huang L Zhuang T Mastroianni A Djemil T Cui T Xia P Impact of small MU/segment and dose rate on delivery accuracy of volumetric-modulated arc therapy (VMAT) J Appl Clin Med Phys 2016 17 203 10 10.1120/jacmp.v17i3.6046569090627167278Open DOISearch in Google Scholar

49 Esposito M, Villaggi E, Bresciani S, Cilla S, Falco MD, Garibaldi C, et al. Estimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methods. Radiother Oncol 2020; 149: 15867. doi: 10.1016/j.radonc.2020.05.014Esposito M Villaggi E Bresciani S Cilla S Falco MD Garibaldi C et al Estimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methods Radiother Oncol 2020 149 15867 10.1016/j.radonc.2020.05.01432416282Open DOISearch in Google Scholar

50 Olaciregui-Ruiz I, Beddar S, Greer P, Jornet N, McCurdy B, Paiva-Fonseca G, et al. In vivo dosimetry in external beam photon radiotherapy: Requirements and future directions for research, development, and clinical practice. Phys Imaging Radiat Oncol 2020; 15: 108-16. doi: 10.1016/j.phro.2020.08.003Olaciregui-Ruiz I Beddar S Greer P Jornet N McCurdy B Paiva-Fonseca G et al In vivo dosimetry in external beam photon radiotherapy: Requirements and future directions for research, development, and clinical practice Phys Imaging Radiat Oncol 2020 15 108 16 10.1016/j.phro.2020.08.003780761233458335Open DOISearch in Google Scholar

51 Consorti R, Fidanzio A, Brainovich V, Mangiacotti F, De Spirito M, Mirri MA, et al. EPID-based in vivo dosimetry for stereotactic body radiotherapy of non-small cell lung tumors: Initial clinical experience. Phys Medica 2017; 42: 157-61. doi: 10.1016/j.ejmp.2017.09.133Consorti R Fidanzio A Brainovich V Mangiacotti F De Spirito M Mirri MA et al EPID-based in vivo dosimetry for stereotactic body radiotherapy of non-small cell lung tumors: Initial clinical experience Phys Medica 2017 42 157 61 10.1016/j.ejmp.2017.09.13329173910Open DOISearch in Google Scholar

52 McCurdy BMC, McCowan PM. In vivo dosimetry for lung radiotherapy including SBRT. Phys Medica 2017; 44: 123–30. doi: 10.1016/j.ejmp.2017.05.065McCurdy BMC McCowan PM In vivo dosimetry for lung radiotherapy including SBRT Phys Medica 2017 44 123 30 10.1016/j.ejmp.2017.05.06528576581Open DOISearch in Google Scholar